Cameron Lloyd-Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cameron Lloyd-Jones has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bryon Drown
The James Tarpo Jr. and Margaret Tarpo Department of Chemistry, Purdue University, West Lafayette, IN, USA
8 shared publications - Neil L. Kelleher
Northwestern University
7 shared publications Kelleher KRG KRG Research Group
4 shared publicationsHenrique Seckler
2 shared publicationsAllan Sniderman
Royal Victoria Hospital-McGill University Health Centre, Montreal, Quebec H3A 1W9, Canada
1 shared publicationHenrique dos Santos Seckler
Department of Chemistry, Department of Molecular Biosciences, Proteomics Center of Excellence, Northwestern University, Evanston, Illinois 60208, United States
1 shared publication
Latest Publications
- 13 April 2023
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (5) , 1455-1465
Preparative Electrophoresis for HDL Particle Size Separation and Intact-Mass Apolipoprotein Proteoform Analysis
The most abundant proteins on high-density lipoproteins (HDLs), apolipoproteins A-I (APOA1) and A-II (APOA2), are determinants of HDL function with 15 and 9 proteoforms (chemical-structure variants), respectively. The relative abundance of these proteoforms in human serum is associated with HDL cholesterol efflux capacity, and cholesterol content. However, the association between proteoform concentrations and HDL size is unknown. We employed a novel native-gel electrophoresis technique, clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE) paired with mass spectrometry of intact proteins to investigate this association. Pooled serum was fractionated using acrylamide gels of lengths 8 and 25 cm. Western blotting determined molecular diameter and intact-mass spectrometry determined proteoform profiles of each fraction. The 8- and 25 cm experiments generated 19 and 36 differently sized HDL fractions, respectively. The proteoform distribution varied across size. Fatty-acylated APOA1 proteoforms were associated with larger HDL sizes (Pearson's R = 0.94, p = 4 × 10-7) and were approximately four times more abundant in particles larger than 9.6 nm than in total serum; HDL-unbound APOA1 was acylation-free and contained the pro-peptide proAPOA1. APOA2 proteoform abundance was similar across HDL sizes. Our results establish CN-GELFrEE as an effective lipid-particle separation technique and suggest that acylated proteoforms of APOA1 are associated with larger HDL particles.
- 13 April 2023
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 22 (5) , 1455-1465
Preparative Electrophoresis for HDL Particle Size Separation and Intact-Mass Apolipoprotein Proteoform Analysis
The most abundant proteins on high-density lipoproteins (HDLs), apolipoproteins A-I (APOA1) and A-II (APOA2), are determinants of HDL function with 15 and 9 proteoforms (chemical-structure variants), respectively. The relative abundance of these proteoforms in human serum is associated with HDL cholesterol efflux capacity, and cholesterol content. However, the association between proteoform concentrations and HDL size is unknown. We employed a novel native-gel electrophoresis technique, clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE) paired with mass spectrometry of intact proteins to investigate this association. Pooled serum was fractionated using acrylamide gels of lengths 8 and 25 cm. Western blotting determined molecular diameter and intact-mass spectrometry determined proteoform profiles of each fraction. The 8- and 25 cm experiments generated 19 and 36 differently sized HDL fractions, respectively. The proteoform distribution varied across size. Fatty-acylated APOA1 proteoforms were associated with larger HDL sizes (Pearson's R = 0.94, p = 4 × 10-7) and were approximately four times more abundant in particles larger than 9.6 nm than in total serum; HDL-unbound APOA1 was acylation-free and contained the pro-peptide proAPOA1. APOA2 proteoform abundance was similar across HDL sizes. Our results establish CN-GELFrEE as an effective lipid-particle separation technique and suggest that acylated proteoforms of APOA1 are associated with larger HDL particles.
- Open Access
- 16 July 2021
- Published by ZappyLab, Inc.
Fibronectin IP for MS v1
Immunoprecipitation of fibronectin for mass spectrometry.
- 16 July 2021
- Published by ZappyLab, Inc.
Open AccessFibronectin IP for MS v1
Immunoprecipitation of fibronectin for mass spectrometry.
- Open Access
- 16 July 2021
- Published by ZappyLab, Inc.
Na+/K+ ATPaseIP for MS v1
Immunoprecipitation of Na+/K+ ATPase for mass spectrometry.
- 16 July 2021
- Published by ZappyLab, Inc.
Open AccessNa+/K+ ATPaseIP for MS v1
Immunoprecipitation of Na+/K+ ATPase for mass spectrometry.
- Open Access
- 16 July 2021
- Published by ZappyLab, Inc.
Troponin I IP for MS v1
Immunoprecipitation of Troponin I for mass spectrometry.
- 16 July 2021
- Published by ZappyLab, Inc.
Open AccessTroponin I IP for MS v1
Immunoprecipitation of Troponin I for mass spectrometry.
- Open Access
- 16 July 2021
- Published by ZappyLab, Inc.
COL4A IP for MS v2
Immunoprecipitation of Collagen IV for mass spectrometry.
- 16 July 2021
- Published by ZappyLab, Inc.
Open AccessCOL4A IP for MS v2
Immunoprecipitation of Collagen IV for mass spectrometry.
- Open Access
- 16 July 2021
- Published by ZappyLab, Inc.
COL4A IP for MS v1
Immunoprecipitation of Collagen IV for mass spectrometry.
- 16 July 2021
- Published by ZappyLab, Inc.
Open AccessCOL4A IP for MS v1
Immunoprecipitation of Collagen IV for mass spectrometry.
- Open Access
- 10 March 2021
- Published by ZappyLab, Inc.
Histone H3.1 (S28Phospho) IP for MS v1
Immunoprecipitation of Histone H3 S28ph for mass spectrometry.
- 10 March 2021
- Published by ZappyLab, Inc.
Open AccessHistone H3.1 (S28Phospho) IP for MS v1
Immunoprecipitation of Histone H3 S28ph for mass spectrometry.
- Open Access
- 10 March 2021
- Published by ZappyLab, Inc.
ApoC3 Ip for MS v1
Method for immunoprecipitation of ApoC3 from human serum for top-down mass spectrometry.
- 10 March 2021
- Published by ZappyLab, Inc.
Open AccessApoC3 Ip for MS v1
Method for immunoprecipitation of ApoC3 from human serum for top-down mass spectrometry.
- Open Access
- 9 March 2021
- Published by ZappyLab, Inc.
Akt1 IP for MS v1
Akt1 IP protocol for MS analysis
- 9 March 2021
- Published by ZappyLab, Inc.
Open AccessAkt1 IP for MS v1
Akt1 IP protocol for MS analysis
- Open Access
- 21 January 2021
- Published by ZappyLab, Inc.
ApoA-I IP for MS v1
Method for immunoprecipitation of ApoA1 from human serum for top-down mass spectrometry.
- 21 January 2021
- Published by ZappyLab, Inc.
Open AccessApoA-I IP for MS v1
Method for immunoprecipitation of ApoA1 from human serum for top-down mass spectrometry.